196 related articles for article (PubMed ID: 37858339)
1. Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma.
Pang L; Guo S; Khan F; Dunterman M; Ali H; Liu Y; Huang Y; Chen P
Cell Rep Med; 2023 Nov; 4(11):101238. PubMed ID: 37858339
[TBL] [Abstract][Full Text] [Related]
2. Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.
Xuan W; Hsu WH; Khan F; Dunterman M; Pang L; Wainwright DA; Ahmed AU; Heimberger AB; Lesniak MS; Chen P
Cancer Immunol Res; 2022 Jun; 10(6):770-784. PubMed ID: 35413115
[TBL] [Abstract][Full Text] [Related]
3. The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma.
Mitchell J; Colon B; Bayik D; Lathia JD
Cell Rep Med; 2023 Nov; 4(11):101293. PubMed ID: 37992680
[TBL] [Abstract][Full Text] [Related]
4. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circLGMN facilitates glioblastoma progression by targeting miR-127-3p/LGMN axis.
Chen B; Wang M; Huang R; Liao K; Wang T; Yang R; Zhang W; Shi Z; Ren L; Lv Q; Ma C; Lin Y; Qiu Y
Cancer Lett; 2021 Dec; 522():225-237. PubMed ID: 34582975
[TBL] [Abstract][Full Text] [Related]
6. The LGMN pseudogene promotes tumor progression by acting as a miR-495-3p sponge in glioblastoma.
Liao K; Qian Z; Zhang S; Chen B; Li Z; Huang R; Cheng L; Wang T; Yang R; Lan J; Lu X; Kong L; Song X; Qiu Y; Lin Y
Cancer Lett; 2020 Oct; 490():111-123. PubMed ID: 32711096
[TBL] [Abstract][Full Text] [Related]
7. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma.
Pang L; Dunterman M; Guo S; Khan F; Liu Y; Taefi E; Bahrami A; Geula C; Hsu WH; Horbinski C; James CD; Chen P
Nat Immunol; 2023 Oct; 24(10):1654-1670. PubMed ID: 37667051
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia potentiates glioma-mediated immunosuppression.
Wei J; Wu A; Kong LY; Wang Y; Fuller G; Fokt I; Melillo G; Priebe W; Heimberger AB
PLoS One; 2011 Jan; 6(1):e16195. PubMed ID: 21283755
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma.
Mohapatra SR; Sadik A; Tykocinski LO; Dietze J; Poschet G; Heiland I; Opitz CA
Front Immunol; 2019; 10():2762. PubMed ID: 31866995
[TBL] [Abstract][Full Text] [Related]
10. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
Li C; Yang J; Lei S; Wang W
Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression.
Sattiraju A; Kang S; Giotti B; Chen Z; Marallano VJ; Brusco C; Ramakrishnan A; Shen L; Tsankov AM; Hambardzumyan D; Friedel RH; Zou H
Immunity; 2023 Aug; 56(8):1825-1843.e6. PubMed ID: 37451265
[TBL] [Abstract][Full Text] [Related]
12. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.
Khan F; Pang L; Dunterman M; Lesniak MS; Heimberger AB; Chen P
J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594466
[TBL] [Abstract][Full Text] [Related]
13. Ferritin light chain promotes the reprogramming of glioma immune microenvironment and facilitates glioma progression.
Li H; Yang C; Wei Y; Li X; Jiang W; Xu Y; Li L; Guo R; Chen D; Gao P; Zhang H; Qin H; Zhang Z; Liu X; Yan D
Theranostics; 2023; 13(11):3794-3813. PubMed ID: 37441589
[No Abstract] [Full Text] [Related]
14. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
[TBL] [Abstract][Full Text] [Related]
15. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
Li C; Guan N; Liu F
J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924
[TBL] [Abstract][Full Text] [Related]
16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
17. Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.
Guo X; Xue H; Shao Q; Wang J; Guo X; Chen X; Zhang J; Xu S; Li T; Zhang P; Gao X; Qiu W; Liu Q; Li G
Oncotarget; 2016 Dec; 7(49):80521-80542. PubMed ID: 27602954
[TBL] [Abstract][Full Text] [Related]
18. HIF1α/HIF2α-Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR-PI3K/AKT signalling pathway with positive feedback under hypoxia.
Wang P; Zhao L; Gong S; Xiong S; Wang J; Zou D; Pan J; Deng Y; Yan Q; Wu N; Liao B
Cell Death Dis; 2021 Mar; 12(4):312. PubMed ID: 33762574
[TBL] [Abstract][Full Text] [Related]
19. Role of LGMN in tumor development and its progression and connection with the tumor microenvironment.
Khan SU; Khan IM; Khan MU; Ud Din MA; Khan MZ; Khan NM; Liu Y
Front Mol Biosci; 2023; 10():1121964. PubMed ID: 36825203
[TBL] [Abstract][Full Text] [Related]
20. An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma.
Yang F; Akhtar MN; Zhang D; El-Mayta R; Shin J; Dorsey JF; Zhang L; Xu X; Guo W; Bagley SJ; Fuchs SY; Koumenis C; Lathia JD; Mitchell MJ; Gong Y; Fan Y
Sci Adv; 2024 Mar; 10(9):eadj4678. PubMed ID: 38416830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
